Restless leg syndrome and sleep disorder. Restless legs syndrome
Conditions
Interventions
Intervention 1: Intervention group: In addition to common treatments, which is pramipexole, the intervention group will receive one 500 mg tablet of Familact probiotic (from Zist takhmir Pharmaceutica
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 55 Years
Inclusion criteria
Inclusion criteria: Definitive diagnosis of restless legs syndrome based on the opinion of the attending physician and the criteria of the International Restless Legs Syndrome Association A history of at least three months of illness Consent to participate in the study
Exclusion criteria
Exclusion criteria: Not taking drugs other than prescribed drugs (psychoactive and sedative) Not suffering from other chronic diseases (kidney failure, diabetes, uremia) Not being pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of the RLS disease. Timepoint: The severity of the disease (restless leg syndrome) of the patients are checked once before the intervention and once after two months after the drug treatment. Method of measurement: IRLS Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: The sleep quality of the patients is checked once before the intervention and once after two months after drug therapy. Method of measurement: Pittsburgh Sleep – PSQI Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohsen Haghighat Khah
Arak University of Medical Sciences
Outcome results
None listed